Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

The study participants were real-life patients prescribed either semaglutide or liraglutide ... And people who drank alcohol reported drinking less on average after starting a GLP-1 drug.

The results showed that semaglutide led to noticeable changes in alcohol-related behavior ... with no heavy drinking days at all, especially during the second month of the study.

The small, 48-subject study – published ... The researchers found that semaglutide treatment did not affect average drinks per calendar day or number of drinking days over that period, but ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.

cirrhosis and liver cancer," stated a press release about the study. Researchers chose to investigate semaglutide as a potential treatment because this class of drug has previously been shown to ...

“From where I practice on a daily basis, in Denmark, we’ve had a huge discussion initially around reimbursement for semaglutide,” Henrik Gudbergsen, MD, PhD (University of Copenhagen, Denmark), who ...

Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 ...